SEB Asset Management AB »

Bicara Therapeutics shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.9M 232k 29.69

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Applied Materials (AMAT)

View all positions for SEB Asset Management AB

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Deep Track Capital
BlackRock
Henderson Group
Jupiter Topco
Red Tree Management
Tpg Gp A
Vanguard Capital Management
Franklin Resources
FMR
Omega Fund Management
State Street Corporation
T. Rowe Price Associates

View all funds holding Bicara Therapeutics